The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Today’s market moved in Ford’s favor as analysts primed optimism around Ford’s energy initiatives alongside its tradi...
A reported name change for Maddox Jolie-Pitt highlights how legal name shifts touch more than identity. This guide br...
As token prices falter, traders are eyeing crypto-linked equities as the potential catalyst for the next crypto recov...
A bold stake move in Hut 8 has sparked a new conversation about concentration, risk, and opportunity in crypto-relate...
Divorce becomes a high-stakes financial exercise when billions are on the line. This guide breaks down practical step...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
XRP rose about 2% as ETF inflows persisted, signaling continued institutional demand even as broader markets stay vol...
XRP is under renewed pressure after a harsh stretch of declines, with traders weighing the risk of deeper losses agai...
Rumors swirl about a SpaceX IPO and what it means for space equities. This guide breaks down the potential good, bad,...
A headline-grabbing $60 million deal with Harry and Meghan raised questions about value, expectations, and how to mea...
XRP-linked ETFs are drawing persistent institutional inflows even as XRP trades in a tight $1.40-$1.47 range. A fresh...